| Dec 31, 2011 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 |
---|
NET LOSS | - | - | - | - | - | -1,578,415 | -16,999,794 | -4,452,279 | -1,877,925 | -34,921,745 | -22,318,056 |
---|
Depreciation and amortization | 588,278 | 831,084 | 844,657 | 1 | 998,189 | 944,012 | 1 | 261,983 | 56,041 | 244,116 | 223,561 |
---|
Impairment loss of Goodwill | - | - | - | - | - | - | - | - | - | 26 | 5 |
---|
Inventories impairment reserve | - | - | - | - | - | - | - | - | - | 93,884 | 59,567 |
---|
Allowance for doubtful accounts | - | - | - | - | - | - | 15 | 20,969 | 146,977 | -53,698 | 1 |
---|
Amortization of discount of convertible promissory notes | - | - | - | - | - | - | - | 104,975 | 2 | 554,292 | 3 |
---|
Profit/Loss on disposal of discontinuing operations and subsidiaries | - | - | - | - | - | - | - | - | - | - | 529,320 |
---|
Accounts receivable | - | - | - | - | - | - | - | -48,387 | - | - | -1,357,394 |
---|
Advances to suppliers | - | - | - | - | - | - | - | - | - | - | -490,168 |
---|
Inventories | -271,495 | 1 | 3 | 2 | -2,074,453 | -2,746,175 | -1,055,168 | -106,440 | - | - | 5 |
---|
Prepayments and other receivables | - | - | - | - | - | - | - | - | - | - | -464,103 |
---|
Operating lease-right of use assets | -393,503 | 29,792 | -238,756 | 769,446 | 909,360 | 316,621 | -720,899 | -93,592 | - | 976,372 | 1 |
---|
Accounts payable, trade | - | - | - | - | - | - | - | - | 5 | -453,738 | 6 |
---|
Advances from customers | - | - | - | - | - | - | - | - | - | - | -970,688 |
---|
Operating lease liabilities | - | - | - | - | - | - | - | - | 45,520 | 915,004 | 1 |
---|
Taxes payable | - | - | - | - | - | - | - | - | - | - | -219,026 |
---|
Other payables and accrued liabilities | 357,650 | -145,394 | 71,115 | 63,311 | 457,288 | 1 | 510,499 | -1,925 | 590,979 | -2,617,765 | 1 |
---|
Net cash used in operating activities from continuing operations | - | 892,708 | -995,080 | -2,473,729 | 159,832 | - | - | -1,094,441 | - | -1,275,725 | -10,255,206 |
---|
Net cash provided by operating activities from discontinued operations | - | - | - | - | - | - | - | -970,351 | 843,382 | - | - |
---|
Net cash used in operating activities | 2 | - | - | - | - | -908,229 | -343,970 | -2,064,792 | -3,517,733 | -1,275,725 | -10,255,206 |
---|
Disposal of Zhuoda | - | - | - | - | - | - | - | - | - | - | 924,740 |
---|
Payment for the acquisition of Qiangsheng, Eurasia and Mingkang Hospitals | - | - | - | - | - | - | - | - | - | 3 | - |
---|
Payment for the acquisition of Phenix Bio Inc | - | - | - | - | - | - | - | - | - | - | 2 |
---|
Deposit for the acquisition of Cogmer | - | - | - | - | - | - | - | - | 3 | -3,065,181 | - |
---|
Discontinued operations-Disposal of Zhuoda | - | - | - | - | - | - | - | - | - | - | -27,117 |
---|
Discontinue operations-held for sale of Zhongshan, qiangsheng, Eurasia and Mingkang | - | - | - | - | - | - | - | - | - | - | 311,277 |
---|
Purchase of property, plant, and equipment | 38,682 | 96,038 | 218,744 | 204,472 | 191,375 | - | - | - | 258,961 | - | - |
---|
Net cash used in investing activities from continuing operations | - | -921,993 | -341,634 | 2 | -407,505 | - | - | 116,976 | -12,424,465 | -696,517 | -536,866 |
---|
Net cash provided by investing activities from discontinued operations | - | - | - | - | - | - | - | 49,741 | 12 | - | - |
---|
Net cash (used in) provided by investing activities | -3,161,644 | - | - | - | - | - | - | 166,717 | -724,465 | -696,517 | -536,866 |
---|
Issuance of common stocks | - | - | - | - | - | - | 500,000 | - | - | - | 5 |
---|
Net proceeds from issuance of convertible promissory notes | - | - | - | - | - | - | - | - | 534,201 | 7 | - |
---|
Repayment of short-term loans | - | - | - | - | - | - | - | - | - | - | 49,882 |
---|
Repayment of long-term loans | - | - | - | - | - | - | - | - | - | - | 486,442 |
---|
Amount financed from (to) related parties | - | - | - | - | - | - | - | - | 148,700 | -478,183 | 4 |
---|
Net cash provided by financing activities from continuing operations | - | -2,093,199 | 2 | 48,251 | -45,160 | - | - | 1 | 4 | 6 | 8 |
---|
Net cash provided by financing activities from discontinued operations | - | - | - | - | - | - | - | 819,609 | - | - | - |
---|
Net cash provided by investing activities | 2 | - | - | - | - | 1 | 211,264 | 2 | 4 | 6 | 8 |
---|
EFFECT OF EXCHANGE RATE ON CASH | - | - | - | - | - | - | - | - | - | - | 85,681 |
---|
(DECREASE) INCREASE IN CASH | - | - | - | - | - | - | - | - | 133,708 | 5 | -2,272,795 |
---|
Cash paid for income tax | 333,615 | 7,948 | 65,413 | - | - | - | 117 | - | 45,178 | 444,633 | 6,092 |
---|
Cash paid for interest expense, net of capitalized interest | - | - | - | - | - | 353,745 | 388,623 | - | 101,417 | 163,883 | 163,326 |
---|
Issuance of shares of Common stock for the equity acquisition of Chongqing Guanzan Technology Co., Ltd. | - | - | - | - | - | - | - | - | 3 | - | - |
---|
Issuance of shares of Common stock for equity acquisition of Zhongshan Chaohu Hospital | - | - | - | - | - | - | - | - | - | 3 | - |
---|
Issuance of shares of Common stock for equity acquisition of Guoyitang Hospital | - | - | - | - | - | - | - | 3 | - | 4 | - |
---|
Issuance of shares of Common stock for equity acquisition of Zhuoda | - | - | - | - | - | - | - | - | - | 1 | - |
---|
Issuance of shares of Common stock for payment of improvements to offices | - | - | - | - | - | - | - | - | - | 696,896 | - |
---|
Goodwill recognized from equity acquisition of Guoyitang Hospital | - | - | - | - | - | - | - | - | 7 | 7 | - |
---|
Outstanding payment for equity acquisition of Zhongshan Chaohu Hospital | - | - | - | - | - | - | - | - | - | 5 | - |
---|
Common stock to be issued upon conversion of convertible promissory notes | - | 960,000 | - | 2 | - | - | - | - | - | - | - |
---|
Issuance of common share for equity acquisition of Mali Hospital | - | - | - | - | - | - | - | - | - | 5 | - |
---|